治疗多支血管冠状动脉疾病和功能性缺血性二尖瓣返流的两阶段杂交策略:病例系列

Q4 Medicine
Motoki Fukutomi MD, PhD , Kenji Wada MD , Tomoya Uchimuro MD , Mizuho Hoshina MD , Takayuki Onishi MD , Shuichiro Takanashi MD, PhD, FJCC , Tetsuya Tobaru MD, PhD, FJCC
{"title":"治疗多支血管冠状动脉疾病和功能性缺血性二尖瓣返流的两阶段杂交策略:病例系列","authors":"Motoki Fukutomi MD, PhD ,&nbsp;Kenji Wada MD ,&nbsp;Tomoya Uchimuro MD ,&nbsp;Mizuho Hoshina MD ,&nbsp;Takayuki Onishi MD ,&nbsp;Shuichiro Takanashi MD, PhD, FJCC ,&nbsp;Tetsuya Tobaru MD, PhD, FJCC","doi":"10.1016/j.jccase.2024.05.004","DOIUrl":null,"url":null,"abstract":"<div><p><span>The optimal treatment strategy of high surgical risk patients with multivessel coronary artery disease (CAD) and functional </span>mitral regurgitation<span><span> (MR) remains controversial. We present two cases in which two-stage hybrid treatment with prior transcatheter mitral valve<span> edge-to-edge repair (TEER) followed by off-pump coronary artery bypass grafting (OPCAB) was successfully performed in patients with CAD and functional ischemic MR. In both cases, the patient showed good </span></span>hemodynamic stability during OPCAB without an increase in MR. A two-stage hybrid strategy with prior TEER followed by OPCAB may be an ideal treatment option for high surgical risk patients with multivessel CAD and functional ischemic MR.</span></p></div><div><h3>Learning objective</h3><p>To recognize the effectiveness of a two-stage hybrid approach with transcatheter edge-to-edge repair and off-pump coronary artery bypass grafting in high surgical risk patients with multivessel coronary artery disease and functional mitral regurgitation.</p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"30 3","pages":"Pages 67-70"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Two-stage hybrid strategy for multivessel coronary artery disease and functional ischemic mitral regurgitation: A case series\",\"authors\":\"Motoki Fukutomi MD, PhD ,&nbsp;Kenji Wada MD ,&nbsp;Tomoya Uchimuro MD ,&nbsp;Mizuho Hoshina MD ,&nbsp;Takayuki Onishi MD ,&nbsp;Shuichiro Takanashi MD, PhD, FJCC ,&nbsp;Tetsuya Tobaru MD, PhD, FJCC\",\"doi\":\"10.1016/j.jccase.2024.05.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>The optimal treatment strategy of high surgical risk patients with multivessel coronary artery disease (CAD) and functional </span>mitral regurgitation<span><span> (MR) remains controversial. We present two cases in which two-stage hybrid treatment with prior transcatheter mitral valve<span> edge-to-edge repair (TEER) followed by off-pump coronary artery bypass grafting (OPCAB) was successfully performed in patients with CAD and functional ischemic MR. In both cases, the patient showed good </span></span>hemodynamic stability during OPCAB without an increase in MR. A two-stage hybrid strategy with prior TEER followed by OPCAB may be an ideal treatment option for high surgical risk patients with multivessel CAD and functional ischemic MR.</span></p></div><div><h3>Learning objective</h3><p>To recognize the effectiveness of a two-stage hybrid approach with transcatheter edge-to-edge repair and off-pump coronary artery bypass grafting in high surgical risk patients with multivessel coronary artery disease and functional mitral regurgitation.</p></div>\",\"PeriodicalId\":52092,\"journal\":{\"name\":\"Journal of Cardiology Cases\",\"volume\":\"30 3\",\"pages\":\"Pages 67-70\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiology Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1878540924000483\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiology Cases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878540924000483","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

多支血管冠状动脉疾病(CAD)和功能性二尖瓣反流(MR)高手术风险患者的最佳治疗策略仍存在争议。我们介绍了两例成功实施两阶段混合治疗的病例,即先进行经导管二尖瓣边缘到边缘修补术(TEER),然后再进行体外冠状动脉旁路移植术(OPCAB),用于治疗患有冠状动脉疾病和功能性缺血性二尖瓣反流的患者。在这两个病例中,患者在 OPCAB 期间均表现出良好的血流动力学稳定性,而 MR 并未增加。学习目的认识经导管边缘到边缘修复术和体外循环冠状动脉旁路移植术两阶段混合方法在多支血管冠状动脉疾病和功能性二尖瓣反流的高手术风险患者中的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Two-stage hybrid strategy for multivessel coronary artery disease and functional ischemic mitral regurgitation: A case series

The optimal treatment strategy of high surgical risk patients with multivessel coronary artery disease (CAD) and functional mitral regurgitation (MR) remains controversial. We present two cases in which two-stage hybrid treatment with prior transcatheter mitral valve edge-to-edge repair (TEER) followed by off-pump coronary artery bypass grafting (OPCAB) was successfully performed in patients with CAD and functional ischemic MR. In both cases, the patient showed good hemodynamic stability during OPCAB without an increase in MR. A two-stage hybrid strategy with prior TEER followed by OPCAB may be an ideal treatment option for high surgical risk patients with multivessel CAD and functional ischemic MR.

Learning objective

To recognize the effectiveness of a two-stage hybrid approach with transcatheter edge-to-edge repair and off-pump coronary artery bypass grafting in high surgical risk patients with multivessel coronary artery disease and functional mitral regurgitation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Cardiology Cases
Journal of Cardiology Cases Medicine-Cardiology and Cardiovascular Medicine
CiteScore
0.90
自引率
0.00%
发文量
177
审稿时长
59 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信